CASI Pharmaceuticals
CASI
#10172
Rank
C$26.43 M
Marketcap
C$1.29
Share price
10.85%
Change (1 day)
-70.86%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -C$61.08 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$31.56 Million. In 2024 the company made an earning of -C$52.38 Million a decrease over its 2023 earnings that were of -C$36.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$61.08 Million16.61%
2024 -C$52.38 Million44.35%
2023 -C$36.28 Million-29.55%
2022 -C$51.5 Million4.43%
2021 -C$49.31 Million-24.56%
2020 -C$65.37 Million4.74%
2019 -C$62.41 Million65.13%
2018 -C$37.8 Million155.07%
2017 -C$14.82 Million13.93%
2016 -C$13.01 Million31.18%
2015 -C$9.92 Million-72.5%
2014 -C$36.05 Million356.62%
2013 -C$7.9 Million-60.55%
2012 -C$20.01 Million218.41%
2011 -C$6.29 Million0.74%
2010 -C$6.24 Million-32.54%
2009 -C$9.25 Million-66.98%
2008 -C$28.01 Million-14.22%
2007 -C$32.65 Million7.04%
2006 -C$30.5 Million27.95%
2005 -C$23.84 Million4.51%
2004 -C$22.81 Million-15.84%
2003 -C$27.11 Million-55.29%
2002 -C$60.62 Million-34.05%
2001 -C$91.92 Million31.73%
2000 -C$69.78 Million31.56%
1999 -C$53.04 Million145.56%
1998 -C$21.6 Million76.4%
1997 -C$12.25 Million36.92%
1996 -C$8.95 Million